Adaptive Biotechnologies Corp (ADPT): Total Assets
$512.74M
As of 2025-12-31
$640.68M
As of 2026-06-30
-15.7%
3-year compound annual growth
-14.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $512.74M | -4.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $539.38M | -18.4% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $661.13M | -22.8% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $856.62M | -7.2% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $923.34M | -17.3% | 2023-02-14, Balance as of period end |
| 2020-12-31 | $1.12B | +22.4% | 2022-02-15, Balance as of period end |
| 2019-12-31 | $912.30M | +174.2% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $332.69M | n/a | 2020-02-26, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $512.74M | -4.9% |
| Vericel Corp (VCEL) | 2025-12-31 | $487.97M | +12.8% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $913.17M | +0.3% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $186.08M | +11.8% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $641.86M | +4.5% |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $1.33B | +26.3% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $1.07B | +5.7% |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | $245.96M | -13.0% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $453.03M | -2.8% |
Compare ADPT, VCEL, IOVA, VXRT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗